|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.760 USD | +5.75% |
|
+2.60% | +69.33% |
| 30/06 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to Russell Small Cap Comp Growth Benchmark | CI |
| 30/06 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 52Cr 45Cr 42Cr 39Cr 73Cr 4.89TCr 74Cr 498.15Cr 193.72Cr 2.41TCr 193.39Cr 189.21Cr 8.34TCr | P/E 2026 * |
-5.71x | P/E 2027 * | -5.18x |
|---|---|---|---|---|---|
| Enterprise Value | 52Cr 45Cr 42Cr 39Cr 73Cr 4.89TCr 74Cr 498.15Cr 193.72Cr 2.41TCr 193.39Cr 189.21Cr 8.34TCr | EV / Sales 2026 * |
4,792x | EV / Sales 2027 * | 3,091x |
| Free-Float |
93.01% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ovid Therapeutics Inc.
| 1 day | +5.75% | ||
| 1 week | +2.60% | ||
| Current month | +2.60% | ||
| 1 month | +15.00% | ||
| 3 months | +7.81% | ||
| 6 months | +55.06% | ||
| Current year | +69.33% |
| 1 week | 2.49 |  | 2.82 |
| 1 month | 2.16 | | 2.84 |
| Current year | 1.36 | | 3.1 |
| 1 year | 0.36 | | 3.1 |
| 3 years | 0.24 | | 4.14 |
| 5 years | 0.24 | | 4.2 |
| 10 years | 0.24 | | 15.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 01/01/2026 | |
Jeffrey Rona
DFI | Director of Finance/CFO | 57 | 02/06/2021 |
Petra Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Levin
CHM | Chairman | 72 | 01/04/2014 |
Karen Bernstein
BRD | Director/Board Member | 73 | 30/09/2015 |
Bart Friedman
BRD | Director/Board Member | 81 | 23/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/06 | Free | Director | 1,30,000 | 0.0697% | ||
| 07/04 | Free | Director | 17,578 | 0.0133% | ||
| 07/04 | Free | Director | 17,578 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.75% | +2.60% | +637.97% | -18.82% | 49Cr | |
| -0.10% | +0.10% | +74.33% | +133.26% | 5.77TCr | |
| -3.80% | -6.24% | +67.04% | +86.36% | 5.47TCr | |
| +1.17% | +5.83% | +16.39% | +468.18% | 2.42TCr | |
| +0.38% | +1.33% | -14.32% | -11.76% | 2.38TCr | |
| -1.20% | +5.09% | +45.15% | -3.81% | 1.98TCr | |
| +3.78% | +5.65% | +44.99% | -26.23% | 1.71TCr | |
| +3.46% | +17.72% | +206.66% | +364.07% | 1.68TCr | |
| -6.93% | +9.58% | +35.64% | - | 1.56TCr | |
| +2.79% | +4.91% | +29.26% | +195.60% | 1.4TCr | |
| Average | +0.53% | +5.12% | +114.31% | +131.87% | 2.44TCr | |
| Weighted average by Cap. | -0.59% | +2.61% | +59.06% | +138.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1L 94.07T 86.7T 80.36T 2L 1.02Cr 2L 10.4L 4L 50.35L 4L 4L 1.74Cr | 2L 1L 1L 1L 2L 1.58Cr 2L 16.12L 6L 78.07L 6L 6L 2.7Cr |
| Net income | -7.71Cr -6.75Cr -6.22Cr -5.76Cr -11Cr -731.95Cr -11Cr -75Cr -29Cr -361.23Cr -29Cr -28Cr -1.25TCr | -8.98Cr -7.86Cr -7.25Cr -6.72Cr -13Cr -852.66Cr -13Cr -87Cr -34Cr -420.81Cr -34Cr -33Cr -1.45TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | $2.760 | +5.75% | 33,12,776 |
| 06/26/06 | $2.610 | -2.97% | 11,55,658 |
| 02/26/02 | $2.690 | +0.37% | 18,87,178 |
| 01/26/01 | $2.680 | -0.37% | 14,13,462 |
| 30/26/30 | $2.690 | -1.10% | 29,70,589 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
